Mikhail Kosiborod
About
In The Last Decade
Mikhail Kosiborod
12 papers receiving 322 citations
Hit Papers
Peers
Comparison fields: 5 of 49
- Endocrinology, Diabetes and Metabolism 229
- Cardiology and Cardiovascular Medicine 183
- Surgery 97
- Molecular Biology 76
- Pulmonary and Respiratory Medicine 48
Countries citing papers authored by Mikhail Kosiborod
This map shows the geographic impact of Mikhail Kosiborod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail Kosiborod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail Kosiborod more than expected).
Fields of papers citing papers by Mikhail Kosiborod
This network shows the impact of papers produced by Mikhail Kosiborod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail Kosiborod. The network helps show where Mikhail Kosiborod may publish in the future.
Co-authorship network of co-authors of Mikhail Kosiborod
This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail Kosiborod. A scholar is included among the top collaborators of Mikhail Kosiborod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail Kosiborod. Mikhail Kosiborod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 0 | |
| 6 | 29 | |
| 7 | 5 | |
| 8 | 9 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 3 | |
| 12 | A Trial to Evaluate the Effect of the Sodium–Glucose Co-Transporter 2 Inhibitor Dapagliflozin on Morbidity and Mortality in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction (DAPA-HF) breakdown → | 259 |
| 13 | 14 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.